These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8782131

  • 21. Methotrexate in severe ankylosing spondylitis: an open study.
    Creemers MC, Franssen MJ, van de Putte LB, Gribnau FW, van Riel PL.
    J Rheumatol; 1995 Jun; 22(6):1104-7. PubMed ID: 7674237
    [Abstract] [Full Text] [Related]

  • 22. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.
    Domènech E, Mañosa M, Navarro M, Masnou H, Garcia-Planella E, Zabana Y, Cabré E, Gassull MA.
    J Clin Gastroenterol; 2008 Apr; 42(4):395-9. PubMed ID: 18277899
    [Abstract] [Full Text] [Related]

  • 23. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate.
    Alsufyani K, Ortiz-Alvarez O, Cabral DA, Tucker LB, Petty RE, Malleson PN.
    J Rheumatol; 2004 Jan; 31(1):179-82. PubMed ID: 14705239
    [Abstract] [Full Text] [Related]

  • 24. Methotrexate in the management of immune mediated cochleovesitibular disorders: clinical experience with 53 patients.
    Salley LH, Grimm M, Sismanis A, Spencer RF, Wise CM.
    J Rheumatol; 2001 May; 28(5):1037-40. PubMed ID: 11361185
    [Abstract] [Full Text] [Related]

  • 25. Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases.
    Michel M, Habibi A, Godeau B, Bachir D, Lahary A, Galacteros F, Fifi-Mah A, Arfi S.
    Semin Arthritis Rheum; 2008 Dec; 38(3):228-40. PubMed ID: 18177923
    [Abstract] [Full Text] [Related]

  • 26. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
    Hartung G, Stehle G, Sinn H, Wunder A, Schrenk HH, Heeger S, Kränzle M, Edler L, Frei E, Fiebig HH, Heene DL, Maier-Borst W, Queisser W.
    Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
    [Abstract] [Full Text] [Related]

  • 27. Methotrexate use in systemic lupus erythematosus.
    Kipen Y, Littlejohn GO, Morand EF.
    Lupus; 1997 Apr; 6(4):385-9. PubMed ID: 9175024
    [Abstract] [Full Text] [Related]

  • 28. Cytokine manipulation by methotrexate treatment in murine experimental systemic lupus erythematosus.
    Dayan M, Segal R, Mozes E.
    J Rheumatol; 1997 Jun; 24(6):1075-82. PubMed ID: 9195512
    [Abstract] [Full Text] [Related]

  • 29. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R, Schleusser B, Herborn G, Karger T.
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [Abstract] [Full Text] [Related]

  • 30. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 31. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis.
    Ideguchi H, Ohno S, Ishigatsubo Y.
    J Clin Rheumatol; 2007 Apr; 13(2):73-8. PubMed ID: 17414533
    [Abstract] [Full Text] [Related]

  • 32. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M, Pacheco-Tena C, Cazarín-Barrientos J, Lino-Pérez L, Goycochea MV, Vazquez-Mellado J, Burgos-Vargas R.
    Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
    [Abstract] [Full Text] [Related]

  • 33. Role of specialty care in the management of patients with systemic lupus erythematosus.
    Urowitz MB, Kagal A, Rahman P, Gladman DD.
    J Rheumatol; 2002 Jun; 29(6):1207-10. PubMed ID: 12064836
    [Abstract] [Full Text] [Related]

  • 34. Undifferentiated connective tissue disease: analysis of 83 patients with a minimum followup of 5 years.
    Mosca M, Neri R, Bencivelli W, Tavoni A, Bombardieri S.
    J Rheumatol; 2002 Nov; 29(11):2345-9. PubMed ID: 12415590
    [Abstract] [Full Text] [Related]

  • 35. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D, Park GS, Paulus HE, Simpson KM, Elashoff D, Cohen SB, Emery P, Dorrier C, Furst DE.
    Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
    [Abstract] [Full Text] [Related]

  • 36. Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD.
    Williams HJ, Alarcon GS, Joks R, Steen VD, Bulpitt K, Clegg DO, Ziminski CM, Luggen ME, St Clair EW, Willkens RF, Yarboro C, Morgan JG, Egger MJ, Ward JR.
    J Rheumatol; 1999 Apr; 26(4):816-25. PubMed ID: 10229402
    [Abstract] [Full Text] [Related]

  • 37. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR.
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [Abstract] [Full Text] [Related]

  • 38. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
    O'Dell JR, Leff R, Paulsen G, Haire C, Mallek J, Eckhoff PJ, Fernandez A, Blakely K, Wees S, Stoner J, Hadley S, Felt J, Palmer W, Waytz P, Churchill M, Klassen L, Moore G.
    Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
    [Abstract] [Full Text] [Related]

  • 39. The use of methotrexate in steroid-resistant systemic lupus erythematosus.
    Rothenberg RJ, Graziano FM, Grandone JT, Goldberg JW, Bjarnason DF, Finesilver AG.
    Arthritis Rheum; 1988 May; 31(5):612-5. PubMed ID: 3288223
    [Abstract] [Full Text] [Related]

  • 40. [Clinical features of undifferentiated connective tissue diseases: analysis of 145 patients].
    Zhang XW, Liu X, Li ZG.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2458-61. PubMed ID: 17156671
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.